Efficacy and Safety of Lenvatinib in Anaplastic Thyroid Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase II study of the efficacy and safety of lenvatinib for anaplastic thyroid cancer (HOPE)
Eur. J. Cancer 2022 Sep 01;173(xx)210-218, T Higashiyama, K Sugino, H Hara, KI Ito, N Nakashima, N Onoda, M Tori, H Katoh, N Kiyota, I Ota, N Suganuma, Y Hibi, T Nemoto, S Takahashi, K Yane, T Ioji, S Kojima, H Kaneda, I Sugitani, M TaharaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.